# The Effects of Melatonin on Elevated Liver Enzymes During Statins Treatment

> **NCT03121521** · PHASE4 · COMPLETED · sponsor: **Medical University of Lodz** · enrollment: 60 (actual)

## Conditions studied

- Hepatopathy

## Interventions

- **DRUG:** Melatonin 10 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03121521
- **Lead sponsor:** Medical University of Lodz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09-01
- **Primary completion:** 2016-09-30
- **Final completion:** 2016-12-15
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03121521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03121521, "The Effects of Melatonin on Elevated Liver Enzymes During Statins Treatment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03121521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*